SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarey Drugs & Pharmaceuticals informs about integrated filing

17 Feb 2025 Evaluate
Aarey Drugs & Pharmaceuticals has informed that the Board of Directors of the Company at its Meeting held on 14th February, 2025 have passed the following resolution: The Board of Directors of the Company has considered and approved the Unaudited Financial Results for the quarter ended 31st December, 2024 along with the Limited Review Report, MD/CFO certification. Company segment is single. The meeting was started at 06:00 pm and was concluded at 07:00 pm.

The above information is a part of company’s filings submitted to BSE.

Aarey Drugs & Pharma Share Price

79.00 0.10 (0.13%)
15-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
Redington 242.50
Amrapali Industries 36.84
Adani Enterprises 2942.85
Rashi Peripheral 560.30
PDS 320.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: